MedPath

Alprazolam

Alprazolam Tablets, USP CIV

Approved
Approval ID

9af2f55c-f624-6fe9-e053-2a95a90ace0c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 30, 2019

Manufacturers
FDA

medsource pharmaceuticals

DUNS: 833685915

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Alprazolam

PRODUCT DETAILS

NDC Product Code45865-993
Application NumberANDA207507
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 30, 2019
Generic NameAlprazolam

INGREDIENTS (8)

ALPRAZOLAMActive
Quantity: 0.5 mg in 1 1
Code: YU55MQ3IZY
Classification: ACTIB
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A CORNInactive
Code: AG9B65PV6B
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Alprazolam - FDA Drug Approval Details